Blood Products in the Management of Abnormal Placentation.

Published

Journal Article (Review)

A critical tool in the successful management of patients with abnormal placentation is an established massive transfusion protocol designed to rapidly deliver blood products in obstetrical and surgical hemorrhage. Spurred by trauma research and an understanding of consumptive coagulopathy, the past 2 decades have seen a shift in volume resuscitation from an empiric, crystalloid-based method to balanced, targeted transfusion therapy. The present article reviews patient blood management in abnormal placentation, beginning with optimizing the patient's status in the antenatal period to the laboratory assessment and transfusion strategy for blood products at the time of hemorrhage.

Full Text

Duke Authors

Cited Authors

  • Gatta, LA; Lockhart, EL; James, AH

Published Date

  • December 2018

Published In

Volume / Issue

  • 61 / 4

Start / End Page

  • 828 - 840

PubMed ID

  • 30285971

Pubmed Central ID

  • 30285971

Electronic International Standard Serial Number (EISSN)

  • 1532-5520

Digital Object Identifier (DOI)

  • 10.1097/GRF.0000000000000400

Language

  • eng

Conference Location

  • United States